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INVOLVEMENT OF TGF-A, ROCK1, DOCK2 AND CAVEOLIN-1 IN
OSTEOARTHRITIS PATHOGENESIS
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Purpose: Osteoarthritis (OA) is a debilitating disease of the joints
characterized by cartilage degradation. To date there is no available
pharmacological treatment to inhibit disease progression, neither is
there a suitable biomarker for early disease prognosis. The aim of the
present study was to investigate the molecular pathways involved
between four identiﬁed OA susceptibility genes and their role in OA
pathogenesis.
Methods: We initially performed a Genome-Wide Association Study
(GWAS) in DNA samples isolated from OA patients that underwent
knee replacement surgery and healthy individuals with no history of
joint disease, all of Greek descent. Analysis of GWAS results revealed
signiﬁcant association between single nucleotide polymorphisms
(SNPs) in transforming growth factor alpha (TGF-a), caveolin-1, rho-
associated coiled coil containing protein kinase 1 (ROCK1) and ded-
icator of cytokinesis-2 (DOCK2) genes and OA. We next proceeded
with evaluation of mRNA and protein expression levels of TGF-a,
ROCK1, DOCK2 and caveolin-1 by real time PCR and western blotting.
Normal articular chondrocytes were next treated with TGF-a and its
effect was assessed by mRNA and protein expression analysis, to
identify the genes/proteins affected and the signaling cascade
activated.
Results: Our results showed that OA chondrocytes demonstrate sig-
niﬁcantly higher TGF-a expression levels compared to normal chon-
drocytes, while the inverse was observed for the expression of ROCK1,
caveolin-1 and DOCK2. Treatment of normal chondrocytes with TGF-a
resulted in activation of ROCK-1 (Rho kinase-1), caveolin-1 and dedi-
cator of cytokinesis-2 (DOCK2) with concurrent upregulation of catab-
olic factors, such as matrix metalloproteinase-13 (MMP-13). The
signaling cascade involved was also investigated.
Conclusions: The suggestion by previous studies that TGF-a and ROCK1
are involved in OA pathogenesis was veriﬁed in the present study by
GWAS and expression analysis, while two novel genes, caveolin-1 and
DOCK2 are postulated for the ﬁrst time to be implicated in disease
mechanism and in response to TGF- a.
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Purpose: Osteoarthritis (OA) is the most common joint disorder and a
leading cause of physical disability. Over the past years, we studied the
complex role of the lipid peroxidation product 4-hydroxynonenal
(HNE) in osteoarthritis (OA). We are the ﬁrst to demonstrate that HNE
level was higher in patients with OA as compared to healthy subjects.
Moreover, we demonstrated that HNE induces a cascade of catabolic
and inﬂammatory events involved in OA process. We recently showed
that the expression of glutathione-s-transferase A4-4 (GSTA4-4), a gene
encoding the HNE-conjugating enzyme GSTA4-4, as well as nuclear
factor erythroid 2-related factor 2 (Nrf2), which regulates GSTA4-4
gene expression, is decreased in human OA cartilage compared to
controls. The objective of the present study is to explore the effects of
protandim, activator of Nrf2, on GSTA4-4 regulation, IL-1b-induced
catabolic and inﬂammatory responses and H2O2-induced oxidative
stress.
Methods: Human OA chondrocytes were pre-treated with different
concentrations of protandim for 1 hour followed by treatment with IL-
1b or H2O2 for 24 hours. Metalloproteinase-13 (MMP-13), nitric oxide
(NO), prostaglandin E2 (PGE2) and HNE were determined using com-
mercial kits. GSTA4-4 mRNA level was assessed by real-time PCR
Results: Our ﬁndings showed that protandim abolished IL-1b-induced
MMP-13, NO, and PGE2 production as well as H2O2-induced HNE
generation. The effect of protandim is mediated, in part, by GSTA4-4 up-
regulation
Conclusions: Collectively, these data strongly represent a new mech-
anism for the control of Nrf2 and GSTA4-4 expression in OA. Indeed,
targetingmechanisms underlying their expression could be a promising
avenue in OA treatment.
